Raymond James & Associates’s DNP Select Income Fund DNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$5.68M Buy
565,350
+26,351
+5% +$241K ﹤0.01% 1572
2024
Q2
$4.43M Buy
538,999
+48,812
+10% +$423K ﹤0.01% 1664
2024
Q1
$4.45M Sell
490,187
-2,858
-0.6% -$25.3K ﹤0.01% 1673
2023
Q4
$4.18M Sell
493,045
-65,680
-12% -$593K ﹤0.01% 1652
2023
Q3
$5.32M Sell
558,725
-28,381
-5% -$286K ﹤0.01% 1421
2023
Q2
$6.15M Sell
587,106
-7,532
-1% -$78.7K 0.01% 1341
2023
Q1
$6.55M Buy
594,638
+28,389
+5% +$323K 0.01% 1285
2022
Q4
$6.37M Buy
566,249
+32,392
+6% +$354K 0.01% 1257
2022
Q3
$5.53M Buy
533,857
+32,151
+6% +$358K 0.01% 1309
2022
Q2
$5.44M Buy
501,706
+79,775
+19% +$899K 0.01% 1348
2022
Q1
$4.99M Buy
421,931
+24,239
+6% +$272K ﹤0.01% 1513
2021
Q4
$4.32M Sell
397,692
-1,384
-0.3% -$14.9K ﹤0.01% 1656
2021
Q3
$4.25M Buy
399,076
+6,838
+2% +$73.3K ﹤0.01% 1596
2021
Q2
$4.1M Buy
392,238
+114,787
+41% +$1.19M ﹤0.01% 1619
2021
Q1
$2.74M Buy
277,451
+22,352
+9% +$228K ﹤0.01% 1807
2020
Q4
$2.62M Buy
255,099
+16,332
+7% +$167K ﹤0.01% 1735
2020
Q3
$2.4M Buy
238,767
+21,639
+10% +$230K ﹤0.01% 1635
2020
Q2
$2.36M Buy
217,128
+2,629
+1% +$28.2K ﹤0.01% 1635
2020
Q1
$2.1M Buy
214,499
+23,253
+12% +$279K ﹤0.01% 1537
2019
Q4
$2.44M Buy
191,246
+18,190
+11% +$232K ﹤0.01% 1705
2019
Q3
$2.23M Buy
173,056
+12,490
+8% +$155K ﹤0.01% 1711
2019
Q2
$1.9M Sell
160,566
-143
-0.1% -$1.66K ﹤0.01% 1833
2019
Q1
$1.85M Buy
160,709
+33,747
+27% +$378K ﹤0.01% 1810
2018
Q4
$1.32M Buy
126,962
+21,287
+20% +$233K ﹤0.01% 1916
2018
Q3
$1.17M Buy
105,675
+5,433
+5% +$59.8K ﹤0.01% 2143
2018
Q2
$1.08M Buy
100,242
+14,411
+17% +$156K ﹤0.01% 2148
2018
Q1
$882K Sell
85,831
-35,666
-29% -$369K ﹤0.01% 2224
2017
Q4
$1.31M Buy
121,497
+421
+0.3% +$4.75K ﹤0.01% 1970
2017
Q3
$1.39M Buy
121,076
+7,998
+7% +$90.3K ﹤0.01% 1888
2017
Q2
$1.25M Buy
113,078
+12,354
+12% +$136K ﹤0.01% 1875
2017
Q1
$1.09M Buy
100,724
+10,197
+11% +$108K ﹤0.01% 1925
2016
Q4
$926K Sell
90,527
-16,742
-16% -$170K ﹤0.01% 1958
2016
Q3
$1.1M Buy
107,269
+12,093
+13% +$128K ﹤0.01% 1828
2016
Q2
$1.01M Buy
95,176
+35,696
+60% +$366K ﹤0.01% 1729
2016
Q1
$595K Buy
59,480
+24,672
+71% +$235K ﹤0.01% 1956
2015
Q4
$312K Buy
34,808
+1,860
+6% +$17.5K ﹤0.01% 2179
2015
Q3
$296K Sell
32,948
-5,644
-15% -$55.9K ﹤0.01% 2140
2015
Q2
$390K Buy
38,592
+5,861
+18% +$62.3K ﹤0.01% 2193
2015
Q1
$344K Buy
32,731
+3,522
+12% +$37K ﹤0.01% 2169
2014
Q4
$308K Buy
29,209
+728
+3% +$7.57K ﹤0.01% 2120
2014
Q3
$288K Buy
28,481
+2,576
+10% +$26.4K ﹤0.01% 2050
2014
Q2
$272K Buy
25,905
+3,214
+14% +$32.5K ﹤0.01% 2077
2014
Q1
$222K Sell
22,691
-306,276
-93% -$2.95M ﹤0.01% 2049
2013
Q4
$3.1M Sell
328,967
-9,964
-3% -$96K 0.02% 735
2013
Q3
$3.26M Sell
338,931
-251,616
-43% -$2.49M 0.03% 650
2013
Q2
$5.8M Buy
+590,547
New +$6.05M 0.05% 374

Other funds holding DNP

Raymond James & Associates's DNP Position: Q3 2024 in Review

Raymond James & Associates increased its DNP Select Income Fund (DNP) stake by 4.9% in Q3 2024, buying an estimated $241K and bringing the position to 565,350 shares worth $5.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1572.

Raymond James & Associates first reported a position in DNP in Q2 2013 and has held it in 46 quarters since. The position peaked at $6.55M in Q1 2023. 301 funds tracked by Wall St. Rank hold DNP as of Q3 2024.

  • Raymond James & Associates held 565,350 shares of DNP Select Income Fund worth $5.68M as of Q3 2024.
  • Raymond James & Associates bought 26,351 DNP Select Income Fund shares in Q3 2024, an estimated $241K.
  • DNP Select Income Fund made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1572 holding.
  • Raymond James & Associates first reported a position in DNP Select Income Fund in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's DNP Select Income Fund position peaked at $6.55M in Q1 2023.
  • 301 funds tracked by Wall St. Rank held DNP Select Income Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.